RosTrace

Tag: MedicalResearch

Robin Hayes

New Studies Reveal Alarming Links Between Tobacco, Cannabis Use and Cardiovascular Disease

New clinical evidence presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Scientific Sessions has drawn renewed attention to the growing cardiovascular risks associated with two of the most widely used substances in the United States: tobacco and cannabis. According to researchers, coronary heart disease deaths tied to tobacco use are projected to increase by nearly 44% within the next five years, while people with cannabis use disorder (CUD) are significantly more likely to suffer from serious heart complications including heart attacks and arrhythmias.

· 4 min read

Sage Bennett

Snakebite Survivor’s Blood Powers Breakthrough in Universal Antivenom Research

Tim Friede, a former truck mechanic from Wisconsin, has spent the past 18 years doing what most people would consider unthinkable: injecting himself with venom from some of the world’s deadliest snakes. His goal was never fame or notoriety — it was to build immunity and, ultimately, save lives. Now, thanks to his extraordinary biological resilience, Friede has helped scientists develop one of the most promising antivenoms to date — a universal treatment that could drastically change how snakebites are managed globally.

· 5 min read

Ash Cooper

Breakthrough in Mitochondrial Medicine: Scientists Develop Tool for Precise mtDNA Editing

In a landmark study that could redefine the landscape of mitochondrial disease research and treatment, scientists in Japan have developed a groundbreaking tool capable of precisely editing mitochondrial DNA (mtDNA) in human cells. The innovation holds promise for both deeper understanding and therapeutic management of devastating conditions like MELAS syndrome and mitochondrial diabetes.

· 4 min read

Ash Cooper

Tailored Biopsies Significantly Improve Patient Outcomes, ROME Trial Finds

CHICAGO – A groundbreaking clinical trial presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 has demonstrated that patients with advanced solid tumors experience significantly improved survival outcomes when treatment is tailored using information from both tissue and liquid biopsies. The findings from the phase II, multicenter ROME trial could redefine the approach to precision oncology and patient care.

· 5 min read

Robin Hayes

MD Anderson Trials Show Breakthrough Results at AACR Annual Meeting 2025

At the prestigious American Association for Cancer Research (AACR) Annual Meeting 2025, researchers from The University of Texas MD Anderson Cancer Center unveiled promising results from several pioneering clinical trials that could redefine treatment paradigms across multiple cancer types. The presentations, covering personalized vaccines, metastasis-directed radiation therapy, and engineered exosome therapeutics, signal major advances in personalized oncology and immunotherapy.

· 3 min read